Form 8-K PERNIX THERAPEUTICS HOLD For: Nov 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Pernix Therapeutics (PTX) Misses Q3 EPS by 19c
November 5, 2015 9:24 AM ESTPernix Therapeutics (NASDAQ: PTX) reported Q3 EPS of ($0.18), $0.19 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $48.6 million versus the consensus estimate of $46.83 million.
For earnings history and earnings-related data on Pernix Therapeutics (PTX) click here.
... More